1 year return (CAGR)
107.38%
Kiniksa Pharmaceuticals Ltd Exchange (NASDAQ, USD)
KNSA
75.34
-0.74 (-0.97%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
62.55%
5 year return (CAGR)
44.55%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.49B
Price/Sales
4.15
Ent value
3.55B
Price/Book
5.33
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
43.25
PEG
-
Forward P/E
46.58
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 76.02 |
| Daily high | 76.95 |
| Daily low | 74.46 |
| Daily Volume | 433K |
| All-time high | 80.92 |
| 1y analyst estimate | 98.00 |
| Beta | 0.09 |
| EPS (TTM) | 0.97 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| KNSA | S&P500 | |
| Current price drop from All-time high | -6.90% | -1.38% |
| Highest price drop | -83.06% | -56.47% |
| Date of highest drop | 18 Oct 2019 | 9 Mar 2009 |
| Avg drop from high | -38.94% | -10.68% |
| Avg time to new high | 33 days | 12 days |
| Max time to new high | 1724 days | 1805 days |
News
